암환자에서의 예방 접종 (항암치료전 혹은 치료중인 환자 기준)

암환자에서의 예방 접종 (항암치료전 혹은 치료중인 환자 기준) 

1> 독감 백신 ===>  추천

2> 폐렴구균 백신 ==> 추천

3> 대상포진 백신 ==> 금지

<미국 CDC guideline>

PCV13 (Pneumococcal Conjugate) Vaccine

 

Medical conditions or other indications for administration of PCV13, and indications for PPSV23 administration and revaccination for adults 19 years of age or older

Risk Group	Underlying Medical Condition	PCV13	PPSV23*
		Recommended	Recommended	Revaccination at 5 years after first dose
Immunocompetent persons	Chronic heart disease†		✓
	Chronic lung disease§		✓
	Diabetes mellitus		✓
	CSF leaks	✓	✓
	Cochlear implants	✓	✓
	Alcoholism		✓
	Chronic liver disease		✓
	Cigarette smoking		✓
Persons with functional or anatomic asplenia	Sickle cell disease/other hemoglobinopathies	✓	✓	✓
	Congenital or acquired asplenia	✓	✓	✓
Immunocompromised persons	Congenital or acquired immunodeficiencies¶	✓	✓	✓
	HIV infection	✓	✓	✓
	Chronic renal failure	✓	✓	✓
	Nephrotic syndrome	✓	✓	✓
	Leukemia	✓	✓	✓
	Lymphoma	✓	✓	✓
	Hodgkin disease	✓	✓	✓
	Generalized malignancy	✓	✓	✓
	Iatrogenic immunosuppression‡	✓	✓	✓
	Solid organ transplant	✓	✓	✓
	Multiple myeloma	✓	✓	✓

• ^*All adults 65 years of age or older should receive a dose of PPSV23, regardless of previous history of vaccination with pneumococcal vaccine
• ^†Including congestive heart failure and cardiomyopathies
• ^§Including chronic obstructive pulmonary disease, emphysema, and asthma
• ^¶Includes B- (humoral) or T-lymphocyte deficiency, complement deficiencies (particularly C1, C2, C3, and C4 deficiencies), and phagocytic disorders (excluding chronic granulomatous disease)
• ^‡Diseases requiring treatment with immunosuppressive drugs, including long-term systemic corticosteroids and radiation therapy

  [출처] 암환자에서의 예방 접종|작성자 허대석